Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, 676 N. St Clair, Suite 2310, Chicago, IL, 60611, USA.
J Assist Reprod Genet. 2022 Jul;39(7):1619-1624. doi: 10.1007/s10815-022-02518-9. Epub 2022 May 19.
To characterize the frozen oocyte disposition preferences of patients undergoing medical and planned fertility preservation.
All oocyte cryopreservation (OC) patients were identified between 2015 and 2018. Demographic information and fertility preservation (FP) indication (medical or planned) were identified for each patient. Oocyte disposition options included disposal, donation to research, or donation to a specified third party, which was decided at the time of initial consent and made available in the electronic medical record. The primary outcome was the disposition selection. Secondary outcomes included differences in demographic variables and disposition selections between medical and planned FP patients using chi-squared analysis.
A total of 336 OC patients with a documented oocyte disposition preference were identified in the study timeframe. Patients were on average 34.5 years old (SD = 5.1) and were predominantly White (70.2%), nulliparous (83.0%), with a BMI of 24.7 (SD = 5.4). A total of 101 patients underwent OC for medical FP and 235 for planned FP. In both groups, the most commonly selected disposition option was donation to research (50% planned, 52% medical), followed by donation to a specified third party (30% planned, 30% medical), and finally disposal of oocytes (20% planned, 18% medical). There were no significant differences in disposition selection between each group. When comparing patient variables between groups, medical FP patients were more likely to be under the age of 35 and were less likely to be nulliparous (p < .001).
This study shows that oocyte disposition choices are similar in patients undergoing OC for medical and planned indications. As donation to research was the most commonly selected option in both groups, it is time to start thinking of streamlining ways to utilize this potential research material in the future.
描述接受医学和计划生育保存的患者对冷冻卵母细胞处置的偏好。
在 2015 年至 2018 年期间确定了所有卵母细胞冷冻保存(OC)患者。为每位患者确定了人口统计学信息和生育保存(FP)指征(医学或计划)。卵母细胞处置选择包括处置、捐赠给研究或捐赠给指定的第三方,这是在初始同意时决定的,并在电子病历中提供。主要结果是处置选择。次要结果包括使用卡方检验比较医学和计划 FP 患者之间的人口统计学变量和处置选择的差异。
在研究期间确定了 336 名有记录的卵母细胞处置偏好的 OC 患者。患者平均年龄为 34.5 岁(标准差=5.1),主要为白人(70.2%),未婚(83.0%),BMI 为 24.7(标准差=5.4)。共有 101 名患者因医学 FP 接受 OC,235 名患者因计划 FP 接受 OC。在这两组中,最常选择的处置选项是捐赠给研究(计划组 50%,医学组 52%),其次是捐赠给指定的第三方(计划组 30%,医学组 30%),最后是处置卵母细胞(计划组 20%,医学组 18%)。两组之间的处置选择没有显著差异。当比较两组之间的患者变量时,医学 FP 患者更年轻,且更可能未婚(p<0.001)。
这项研究表明,接受医学和计划指征的 OC 患者的卵母细胞处置选择相似。由于捐赠给研究是两组中最常选择的选项,因此现在是时候开始考虑简化未来利用这种潜在研究材料的方法了。